Bibliographic
Brevetti EPO No.3589661 2023.11.01
Brevetti EPO
(10) Registration Number and Date
2024000129 2024.03.26
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2024/000129 2018.02.28
(40) Publication Number and Date
SM /T/2024/000129 2024.03.26
(30) Priority Details
US 201762486876 P
2017.04.18
US 201762466239 P
2017.03.02
US 201762469317 P
2017.03.09
(51) IPC Classes
(71/73) Applicant
(72) Inventor
(IT) BENYUNES, Mark, C. : c/o Genentech Inc.1 DNA Way, South San Francisco, CA 94080, US
(IT) ROSS, Graham, Alexander : 12 Digswell Road, Welwyn Garden CityHertfordshire AL8 7PA, GB
(74) Representative Name
(IT) MARI, Marco Giovanni : Via Tre Settembre, 154, 47891 Dogana RSM, SM
(54) Title
(IT) TRATTAMENTO ADIUVANTE DEL CANCRO MAMMARIO POSITIVO A HER2
(EN) ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
(57) Abstract
(58) Citations
Document
Document Type Date Action
Traduzione 2024.06.28
Event
Event NameDateStatus
Filing2018.02.28Filed
Ricevuta pagamento annualita 72024.02.22Payed
Brevetto EPO concesso2024.03.26Published
Ricevuta pagamento annualita 82025.01.22Payed
Ricevuta pagamento annualita 92026.01.22Payed
Description
Claims